- Global Pharma News & Resources

Global Glycobiology (Enzymes, Instruments, Reagents and Kits) Market, Competition, Forecast & Opportunities, 2025 -

DUBLIN--(BUSINESS WIRE)--The "Global Glycobiology Market 2025" report has been added to's offering.

The Global Glycobiology Market was valued at USD 938.76 Million and is expected to grow at a doubled digit CAGR of 13.83% during the forecast period.

The Global Glycobiology Market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines. This in turn has increased the drug discovery process around the globe, which is anticipated to positively impact growth of the market during the forecast period.

Also, increasing grants by different governments especially in the developing nations for R&D activities is further expected to bolster the growth of the market over the next few years. Furthermore, increasing research activities in glycomics, technological advancements and rising government initiatives is also among the major drivers for the Global Glycobiology Market.

The Global Glycobiology Market is segmented based on product, application, End-user, company, and region. Based on product, the market can be categorized into enzymes, instruments, reagents, and kits. Among the following, enzymes contribute the majority of share in the market nearly about 35%.

Based on enzymes, they can be further bifurcated into glycosidases & neuramidases, glycosyltransferases & sialytransferases, carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases and others. The glycosidases & neuramidases segment is leading the market is expected to dominate the market during the forecast period as well. This can be ascribed to their pivotal role in metabolism, antibacterial defense & pathogenesis, glycosidase probe design for ABPP represents an important task in chemical proteomic & glycomic research.

Based on instruments, the market is fragmented into HPLC, mass spectrometry, MALDI-TOF, antibody arrays, lectin arrays, and others. The HPLC segment is attributed to dominate the market in the coming years. Based on reagents, the market is segmented into glycoproteins, oligosaccharides, monosaccharides, and others.

Based on kits, the glycobiology market is sub-segmented into glycan releasing kit, glycan purification kit, glycan labeling kit, and others.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Glycobiology Market

4. Executive Summary

5. Voice of Customer

5.1. Brand Awareness

5.2. By Application

5.3. Factors driving the Glycobiology Market

6. Global Glycobiology Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product (Enzymes, Instruments, Reagents and Kits) By Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others) By Instruments (HPLC, Antibody arrays, Lectin arrays, MALDI-TOF, Mass spectroscopy, Others) By Reagents (Monosaccharides, Glycoproteins, Oligosaccharides, Others) By Kits (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others)

6.2.2. By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others)

6.2.3. By End-user (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others)

6.2.4. By Company (2019)

6.2.5. By Region

6.3. Product Market Map

7. North America Glycobiology Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product

7.2.2. Application

7.2.3. By End-user

7.2.4. By Country

7.3. North America: Country Analysis

8. Europe Glycobiology Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product

8.2.2. Application

8.2.3. By End-user

8.2.4. By Country

8.3. Europe: Country Analysis

9. Asia Pacific Glycobiology Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.3. Market Share & Forecast

9.3.1. By Product

9.3.2. Application

9.3.3. By End-user

9.3.4. By Country

9.4. Asia Pacific: Country Analysis

10. South America Glycobiology Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product

10.2.2. Application

10.2.3. By End-user

10.2.4. By Country

10.3. South America: Country Analysis

11. Middle East and Africa Glycobiology Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Type of Enzyme

11.2.2. By Type of Kit

11.2.3. By Application

11.2.4. By End-user

11.2.5. By Country

11.3. MEA: Country Analysis

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Merck & Co., Inc.

14.2. Agilent Technologies, Inc.

14.3. Thermo Fisher Scientific

14.4. New England Biolabs, Inc.

14.5. Shimadzu Corporation

14.6. Takara Bio Inc.

14.7. Waters Corporation

14.8. Asparia Glycomics S.L.

14.9. Bruker Corporation

14.10. RayBiotech, Inc.

14.11. Z Biotech, LLC.

14.12. Chemily Glycoscience

14.13. Dextra Laboratories Ltd.

14.14. Lectenz Bio

14.15. Ludger Ltd

14.16. R&D Systems, Inc.

14.17. Glycotope GmbH

14.18. Danaher Corporation

14.19. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)

14.20. Bio-Rad Laboratories

15. Strategic Recommendations

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 14-Jan-2021